Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

DNA

Donaco (DNA)

Donaco International Ltd
Von:
Sortieren nach:
 Showing the most relevant articles for your search:ASX:DNA
DatumZeitQuelleÜberschriftSymbolFirma
11/11/201500h52The Motley FoolPacker backs Crown Resorts Ltd with $200 million betASX:DNADonaco International Ltd
27/03/200916h13Dow Jones NewsUPDATE: FDA 'Unclear' If Avastin Data Backs Expanded ApprovalNYSE:DNAGenentech Inc. (Delisted 3/27/09)
27/03/200915h35Dow Jones NewsFDA 'Unclear' If Genentech Drug Data Backs Expanded ApprovalNYSE:DNAGenentech Inc. (Delisted 3/27/09)
26/03/200910h23Dow Jones NewsUPDATE: Roche Effectively Seals $46.8 Billion Genentech TakeoverNYSE:DNAGenentech Inc.
26/03/200908h05Dow Jones NewsRoche Completes Genentech Takeover, Holds 93.2%NYSE:DNAGenentech Inc.
26/03/200907h37Dow Jones NewsRoche Completes Tender Offer For Genentech, Holds 93.2%NYSE:DNAGenentech Inc.
25/03/200913h44Dow Jones News2nd UPDATE: Ethos Recommends UBS Holders Reject New Pay PlanNYSE:DNAGenentech Inc.
25/03/200911h43Dow Jones NewsUPDATE: Ethos Recommends UBS Holders Reject New Pay Plan At AGMNYSE:DNAGenentech Inc.
24/03/200919h08Dow Jones NewsRoche Says RiskMetrics Backs Genentech Takeover At $95/ShareNYSE:DNAGenentech Inc.
19/03/200918h09Dow Jones NewsEU Panel Backs Novartis' Glivec In Kit-positive GISTNYSE:DNAGenentech Inc.
18/03/200914h55Dow Jones NewsRoche Shares Down On Actemra; Herceptin Success Of Little HelpNYSE:DNAGenentech Inc.
18/03/200908h16Dow Jones NewsRoche's Herceptin Extends Life In Aggressive Stomach CancerNYSE:DNAGenentech Inc.
18/03/200907h33Dow Jones NewsRoche: Herceptin Prolongs Life In Stomach CancerNYSE:DNAGenentech Inc.
18/03/200905h32Dow Jones NewsUPDATE: Chugai,Roche Face Arthritis Drug Side Effect SetbackNYSE:DNAGenentech Inc.
18/03/200902h05Dow Jones NewsChugai:Undeniable Actemra Side Effects Tied To Patient DeathsNYSE:DNAGenentech Inc.
17/03/200923h54Dow Jones NewsBiotechnology Group Praises Biologic Drugs BillNYSE:DNAGenentech Inc.
17/03/200921h29Dow Jones News5th UPDATE: Pfizer Sells $13.5 Billion Bond Offering TuesdayNYSE:DNAGenentech Inc.
17/03/200920h25Dow Jones News4th UPDATE: Pfizer Sells $13.5 Billion Bond Offering TuesdayNYSE:DNAGenentech Inc.
17/03/200918h53Dow Jones News3rd UPDATE: Pfizer Launches $13.5 Billion Bond Offer; Pricing TuesdayNYSE:DNAGenentech Inc.
17/03/200918h01Dow Jones News2ndUPDATE:Pfizer Launches $13.5 Billion Bond Offering For Pricing TuesdayNYSE:DNAGenentech Inc.
17/03/200917h13Dow Jones NewsUPDATE:Pfizer Launches $13.5 Billion Bond Offering For Pricing TuesdayNYSE:DNAGenentech Inc.
16/03/200921h57Dow Jones NewsMARKET SNAPSHOT: Corporate Cash Reserves, Cheap Stocks Could Trigger More M&ANYSE:DNAGenentech Inc.
16/03/200919h49Dow Jones NewsMARKET SNAPSHOT: Corporate Cash Warchests, Cheap Stocks Could Trigger More M&ANYSE:DNAGenentech Inc.
16/03/200907h37Dow Jones NewsRoche Acquires Innovatis AG For EUR15 MillionNYSE:DNAGenentech Inc.
13/03/200913h45Dow Jones NewsGenentech-Roche Deal Shows Attraction Of Biotech AssetsNYSE:DNAGenentech Inc.
12/03/200921h42Dow Jones NewsGenentech-Roche Deal Shows Attraction Of Biotech AssetsNYSE:DNAGenentech Inc.
12/03/200920h15Dow Jones NewsUS Antitrust Review May Not Pose Threat To Drug Co MergersNYSE:DNAGenentech Inc.
12/03/200915h06Dow Jones NewsUPDATE: Gilead To Buy CV Therapeutics For $1.4 BillionNYSE:DNAGenentech Inc.
12/03/200912h10Dow Jones News4th UPDATE: Roche Seals $46.8 Billion Genentech DealNYSE:DNAGenentech Inc.
12/03/200909h32Dow Jones News3rd UPDATE: Roche Seals $46.8 Billion Genentech DealNYSE:DNAGenentech Inc.
 Showing the most relevant articles for your search:ASX:DNA